Private Credit & Restructuring

More Time Is Not a Repayment Plan

Recent private-credit disclosures raise a practical question for owners and boards: what will actually change before the next deadline?

Article Details

Type

Market commentary

Audience

Business owners, boards, lenders, and their advisors

Reviewed By

Neil MassaDennis WilkesErik MortonLouis R. Dienes

CMBG Restructuring & Fiduciary Services Team

Publication

Published

November 16, 2026

Updated

Coverage

Private CreditDebt RestructuringCash FlowBusiness Planning

Important Scope Note

Insolvency decisions carry significant legal and personal-liability consequences and depend heavily on specific facts. Please contact us before acting.

Article Summary

A lender agreeing to wait can be good news. It gives a business room to fix a problem without forcing an immediate sale or shutdown. But there is a question that belongs in the same conversation: what will be different when the new deadline arrives? Recent private-credit disclosures make that question harder to avoid.

Article Section

One Loan Tells a Striking Story

Blue Owl’s reported value of the same $112 million Loparex second-lien loan
Valuation dateReported fair valueValue per dollar of principal
December 31, 2025$97.72 million87.25 cents
June 30, 2026$5.60 million5 cents
September 30, 2026$3.64 million3.25 cents

Reported valuations, not final recoveries. Cents per dollar are fair value divided by the $112 million principal. The June and September filings are linked below.

Source: Blue Owl Capital Corporation, Q3 2026 Form 10-Q; Q2 filing linked below.

Blue Owl Capital Corporation reported a $112 million second-lien loan to Loparex, a manufacturer of release liners used with products such as labels and tapes. The value assigned to that same loan changed dramatically.

These figures come from Blue Owl’s June filing and September filing. They are reported valuations, not the amount ultimately recovered.

On November 2, Loparex announced that it had completed a recapitalization, reducing debt and improving liquidity. Its announcement did not disclose the recovery on this particular loan.

Both things can be true: a business can emerge with a stronger balance sheet, while an existing lender faces a very different investment from the one it originally made. Keeping the company operating and repaying every creditor in full are not the same outcome.

Article Section

This Isn’t a Verdict on the Entire Market

One troubled loan does not establish that private credit is broken. There are encouraging figures, too. Proskauer’s quarterly index of U.S. senior-secured and unitranche loans showed defaults declining to 2.41% in the third quarter from 2.51% in the second.

The useful response is neither panic nor reassurance based on an average. It is a closer look at the particular borrower, the cash coming in, and the obligations coming due.

That is the same distinction we explored in Private Credit and the Test of Repayment: the value assigned to an investment and the cash it eventually produces are different things.

Article Section

Buying Time Can Make the Bill Bigger

Payment-in-kind interest illustrates the tradeoff. Instead of paying interest in cash, the borrower adds it to the debt.

Consider a hypothetical situation: a company owes $100 million at 11% interest, compounded annually. If it makes no payments and incurs no additional fees, the balance reaches almost $137 million after three years.

That arrangement may preserve cash today. It also leaves a larger obligation for tomorrow. PIK can be part of a loan’s original structure; it is not automatically evidence of trouble. Adding it because a borrower can no longer make cash payments raises a different question.

The point is not that an extension or payment concession is inherently bad. It is that relief today needs to be connected to a credible source of repayment later.

Article Section

What Changes Before the Deadline?

For an owner or board, I would start with four questions:

  • What improves cash flow? Identify the actual cost reductions, pricing changes, collections, or asset sales. Put dates next to them.
  • What funds the business until then? Separate committed money from financing someone hopes to arrange.
  • What happens if the plan runs late? Test slower customer payments and a delayed refinancing against payroll, suppliers, and debt payments.
  • When do we reconsider? Agree on milestones before the company misses them, not after the remaining cash has been spent.

If the plan depends on a revolving facility, check what is actually available under the credit line. An unused commitment is not necessarily money the company can draw whenever it needs it.

These questions also help distinguish a workable turnaround from a plan that simply moves the same shortfall into another month.

Article Section

Our Takeaway

More time can be valuable. A company may need it to collect receivables, complete a sale, reduce costs, or bring in new capital.

But ‘the lender will probably extend’ is an assumption, not an operating plan.

The useful board conversation is straightforward: what changes, who is responsible, when does it improve cash, and what do we do if it doesn’t?

That is how an extension becomes a tool for recovery rather than just a later due date.

Behind this resource

About the authors

Jim Baer

Jim Baer

Founder & CEO

Jim Baer founded CMBG Advisors and advises boards, executives and business owners on corporate restructuring, financing, mergers and acquisitions, and corporate securities matters. His experience combines legal practice with executive leadership and strategic business advisory.

Lisa Van Eyssen

Lisa Van Eyssen

Executive Vice President, Head of Administration

Lisa leads CMBG's restructuring specialists and serves as the day-to-day executive contact for clients. Her work spans asset sales and liquidations, creditor claims and distributions, landlord negotiations, and employee and tax matters.

Reviewed by

CMBG Restructuring & Fiduciary Services Team

Neil Massa

Neil Massa

Chief Operating Officer, Head of Sales & Marketing

Neil leads CMBG's investigators and recovery specialists, overseeing wind-downs, asset sales, liquidations, and inventory and records management. His background includes more than 35 years in law enforcement and directing forensic investigations involving asset diversion and fraudulent transfers.

Dennis Wilkes

Dennis Wilkes

Head of Information Technology

Dennis brings more than 25 years of IT consulting experience with small businesses, large campuses and municipal facilities. He works across Mac and Microsoft environments, including network configuration and security.

Erik Morton

Erik Morton

Strategic Partner — New York

Erik brings deep expertise in SaaS and ecommerce transactions to CMBG's strategic network. Based in Albany, he extends the firm's reach across the Northeast, advising on founder liquidity events, roll-up strategies, and structured transactions for technology companies navigating growth and transition.

Louis R. Dienes

Louis R. Dienes

Strategic Partner — San Diego

Louis is a seasoned M&A attorney with more than two decades of experience handling mergers, acquisitions, and divestitures in technology and other growth industries. He has represented clients in more than $10 billion of concluded transactions, including complex domestic and cross-border deals. His partnership with CMBG strengthens the firm's transactional and restructuring capabilities across Southern California and beyond.